Ryne C. Ramaker
Oncology
Durham, NC 27709
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
ASO Visual Abstract: Inpatient Palliative Care and Procedural Intensity in Patients with Hepatopancreatobiliary Cancers at the End of Life.
Journal: Annals of surgical oncology
Published: July 25, 2026
Inpatient Palliative Care and Procedural Intensity in Patients with Hepatopancreatobiliary Cancers at the End of Life.
Journal: Annals of surgical oncology
Published: April 06, 2026
Erratum: Prevalence and Clinical Characteristics of Germline Epidermal Growth Factor Receptor Mutations in the Southeastern United States.
Journal: JCO precision oncology
Published: March 02, 2026
Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancer.
Journal: Journal of gastroenterology
Published: January 30, 2026
Prevalence and Clinical Characteristics of Germline Epidermal Growth Factor Receptor Mutations in the Southeastern Unites States.
Journal: JCO precision oncology
Published: January 21, 2026
Profiling KRAS mutations in whole blood by error-corrected maximum depth sequencing.
Journal: NPJ precision oncology
Published: December 12, 2025
Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysis.
Journal: NPJ precision oncology
Published: December 11, 2025
Preparing for the Inevitable: Early Comprehensive Genomic Profiling for Patients With Localized Pancreatic Ductal Adenocarcinoma.
Journal: JCO oncology practice
Published: November 14, 2025
Comparing traditional versus total neoadjuvant chemotherapy for patients with localized pancreatic cancer.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: October 23, 2025
QIM25-219: Identifying Barriers to Comprehensive Genomic Profiling for Patients in Academic and Community Oncology Centers.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
CLO25-095: Baseline Genomic Alterations as Predictors of Response to Anti-HER2 Therapy in HER2-Amplified Advanced Colorectal Cancer (aCRC).
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
Cardiovascular Disease Pathogenicity Predictor (CVD-PP): A Tissue-Specific In Silico Tool for Discriminating Pathogenicity of Variants of Unknown Significance in Cardiovascular Disease Genes.
Journal: Circulation. Genomic and precision medicine
Published: October 29, 2024
Last Updated: 09/26/2026